GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,011,000 | -7.8% | 1,095,810 | 0.0% | 0.21% | +20.5% |
| Q1 2022 | $37,959,000 | +40.8% | 1,095,810 | +19.0% | 0.17% | +69.3% |
| Q4 2021 | $26,952,000 | -8.9% | 920,810 | -20.7% | 0.10% | -16.5% |
| Q3 2021 | $29,580,000 | +12.6% | 1,160,900 | +54.8% | 0.12% | +6.1% |
| Q2 2021 | $26,265,000 | -14.1% | 750,000 | 0.0% | 0.11% | -39.7% |
| Q1 2021 | $30,563,000 | +41.1% | 750,000 | +50.0% | 0.19% | +44.3% |
| Q4 2020 | $21,655,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |